Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

6 Pharmaceutical Stocks to Sell Now
InvestorPlace
Saturday, September 29, 2012 - 12:30pm
tags:
Warner Chilcott, Hi Tech Pharmacal, Optimer Pharmaceuticals, Avanir, Pemix Therapeutic Holdings, Horizon Pharma
Dr. Reddy’s Announces the Launch of Montelukast Sodium Oral Granules
Enhanced Online News
Saturday, September 29, 2012 - 12:28pm
tags:
Dr Reddy's, Singulair, generics
Should Investors Be Angry With Big Pharma?
Motley Fool
Saturday, September 29, 2012 - 12:27pm
tags:
This Drug Could Be a Game-Changer for Sarepta (and a Savior for Thousands)
Motley Fool
Saturday, September 29, 2012 - 12:26pm
tags:
Sarepta Therapeutics, muscular dystrophy
Lilly Releases Phase II Results for Monoclonal Antibody Ramucirumab in Lung Cancer
Yahoo/PR Newswire
Saturday, September 29, 2012 - 12:25pm
tags:
ramucirumab, lung cancer, Eli Lilly
New Four- and Five-Year Survival Data for YERVOY® (ipilimumab) in Treatment-Naïve and Previously-Treated Metastatic Melanoma Presented at the ESMO 2012 Congress (European Society for Medical Oncology)
Yahoo/BusinessWire
Saturday, September 29, 2012 - 12:24pm
tags:
Yervoy, melanoma, Bristol-Myers Squibb
CEO Gaffe of the Week: Peregrine Pharmaceuticals
Motley Fool
Saturday, September 29, 2012 - 12:23pm
tags:
Peregrine Pharmaceuticals
Abbott Laboratories (ABT): Today's Featured Drugs Laggard
The Street
Saturday, September 29, 2012 - 12:16pm
tags:
Abbott Laboratories
Sanofi (SNY): Today's Featured Health Care Laggard
The Street
Saturday, September 29, 2012 - 12:15pm
tags:
Sanofi
Pharma Is on Fire
Motley Fool
Saturday, September 29, 2012 - 12:14pm
tags:
Action Pharma
Abbott's Humira (adalimumab) Receives U.S. FDA Approval for the Treatment of Adult Patients with Moderate to Severe Ulcerative Colitis
Yahoo/PR Newswire
Saturday, September 29, 2012 - 12:14pm
tags:
Abbott Laboratories, Humira, ulcerative colitis
Investors may overlook Abbott executive's false degrees
Reuters
Saturday, September 29, 2012 - 12:12pm
tags:
Abbott Laboratories
This Stock Rocks as Its Drug Rolls Ahead
Motley Fool
Saturday, September 29, 2012 - 12:11pm
tags:
Ariad Pharmaceuticals, Ponatinib, chronic myelogenous leukemia, leukemia
Is This Pharma Stock a Good Investment?
Motley Fool
Saturday, September 29, 2012 - 12:08pm
tags:
Questcor Pharmaceuticals
Insmed Ignites Higher and 4 Healthcare Stocks to Analyze Now
Wall Street Cheat Street
Saturday, September 29, 2012 - 12:08pm
tags:
Insmed, Dendreon, Peregrine Pharmaceuticals, Vivus, Arena Pharmaceuticals
What's Fueling Savient's Run?
Motley Fool
Saturday, September 29, 2012 - 12:06pm
tags:
Savient
ARIAD Presents Initial Clinical Proof-of-Concept of AP26113 in Patients with Non-Small Cell Lung Cancer at ESMO 2012 Congress
Yahoo/BusinessWire
Saturday, September 29, 2012 - 12:02pm
tags:
non-small cell lung cancer, Ariad Pharmaceuticals, AP26113
Exelixis Announces Data Presentation for GDC-0973 (XL518)
Yahoo/BusinessWire
Saturday, September 29, 2012 - 11:59am
tags:
Exelixis, GDC-0973, XL518, melanoma
Bayer’s Nexavar May Have Prolonged Life in Some Lung Patients
Bloomberg
Saturday, September 29, 2012 - 11:57am
tags:
Nexavar, Bayer, lung cancer
Glaxo Two-Drug Melanoma Combo Slows Cancer in Study
Bloomberg
Saturday, September 29, 2012 - 11:55am
tags:
GSK, melanoma, dabrafenib, trametinib

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.